Biospecifics Technologies (BSTC) Reports Q2 EPS of $0.24

Biospecifics Technologies (NASDAQ: BSTC) reported Q2 EPS of $0.24, versus $0.08 reported last year. Revenue for the quarter came in at $4.7 million versus the consensus estimate of $2.6 million.

For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• Advance Auto Parts falls on revenue miss, weak guidance